Every recall we track for QuVa Pharma, Inc. — 38 in all — plus the complaints and injury reports the public filed about them.
QuVa Pharma recalls specific lots of Methohexital Sodium compounded drug due to failed impurities and degradation specifications. This recall affects certain prescription-only products sold in Texas.
QuVa Pharma recalls R.E.C.K. (Ropivacaine HCl, Epinephrine, Clonidine HCl, Ketorolac Tromethamine) in Sodium Chloride Solution for periarticular use due to particulate matter. This compounded drug may cause blockages if injected.
QuVa Pharma recalls fentanyl citrate injections with potential lack of sterility. Affected lots expire by April 2025. Consumers should contact for details.
QuVa Pharma recalls fentanyl and bupivacaine solution for epidural use due to lack of sterility assurance. This compounded product may cause infections if used improperly. Check NDC 70092-1255-75 and lots 10140259-10140688.
QuVa Pharma recalls specific fentanyl injections due to lack of sterility assurance. Affected lots expire April 2025. Consumers should not use these products.
QuVa Pharma recalls oxyTOCIN 30 Units/500mL IV solution due to incorrect sodium chloride concentration (0.45% instead of 0.9%). This compounded product for institutional use may cause complications if administered improperly.